Výsledky vyhledávání

Akademický článek

Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells.

Autor: Teh CE; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Peng H; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Luo MX; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Tan T; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia., Trussart M; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, Australia., Howson LJ; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Chua CC; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.; Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia., Muttiah C; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; The Royal Melbourne Hospital, Melbourne, VIC, Australia., Brown F; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia., Ritchie ME; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Wei AH; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; The Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Roberts AW; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; The Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Bryant VL; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; The Royal Melbourne Hospital, Melbourne, VIC, Australia., Anderson MA; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lindeman GJ; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.; The Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Huang DCS; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Thijssen R; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Gray DHD; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.

Publikováno v: Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2733-2745.

Zobrazit plný text záznamu

Akademický článek

PALVEN: phase Ib trial of palbociclib, letrozole and venetoclax in estrogen receptor- and BCL2-positive advanced breast cancer.

Autor: Muttiah C; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; The University of Melbourne, Parkville, VIC, 3010, Australia., Whittle JR; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; The University of Melbourne, Parkville, VIC, 3010, Australia., Oakman C; Western Health, Sunshine Hospital, St Albans, VIC, 3021, Australia., Lindeman GJ; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; The Walter & Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.; The University of Melbourne, Parkville, VIC, 3010, Australia.

Publikováno v: Future oncology (London, England) [Future Oncol] 2022 May; Vol. 18 (15), pp. 1805-1816. Date of Electronic Publication: 2022 Feb 21.

Zobrazit plný text záznamu

Akademický článek

Mechanism of miRNAs and miRNA-mRNA Regulatory Networks in Modulating Drug Resistance in HER2-Positive Breast Cancer: An Integrative Bioinformatics Approach.

Autor: Vo, Thanh Hoa¹ (AUTHOR) thanhhoa.vo@postgrad.wit.ie, McNeela, Edel A.¹ (AUTHOR) edel.mcneela@setu.ie, O'Donovan, Orla¹ (AUTHOR) orla.odonovan@setu.ie, Rani, Sweta¹ (AUTHOR) sweta.rani@setu.ie, Mehta, Jai Prakash² (AUTHOR) jai.mehta@setu.ie

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p3962. 15p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre study.

Autor: Kwan EM; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia., Semira MC; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Bergin ART; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Muttiah C; Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia., Beck S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Anton A; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Campbell D; Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia., Wong S; Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia., Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gibbs P; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

Publikováno v: Internal medicine journal [Intern Med J] 2019 Nov; Vol. 49 (11), pp. 1378-1385.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání